143 related articles for article (PubMed ID: 4577443)
1. Characteristics of pentazocine dependence in hospitalized patients after naloxone administration.
Sandoval RG; Wang RI
Psychopharmacologia; 1973 Jun; 30(3):205-15. PubMed ID: 4577443
[No Abstract] [Full Text] [Related]
2. Use and misuse of pentazocine. A follow-up.
JAMA; 1973 Sep; 225(12):1530-1. PubMed ID: 4740729
[No Abstract] [Full Text] [Related]
3. Cutaneous complications of parenteral pentazocine.
Winfield JB; Greer K
South Med J; 1974 Mar; 67(3):292-4. PubMed ID: 4814178
[No Abstract] [Full Text] [Related]
4. Pharmacological study of pentazocine-naloxone combination: interest as a potentially non abusable oral form of pentazocine.
Legros J; Khalili-Varasteh H; Margetts G
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):11-21. PubMed ID: 6541897
[TBL] [Abstract][Full Text] [Related]
5. [Pentazocine-induced eosinophilia. Case report].
Friedrich K; Henning H
Med Klin; 1974 Nov; 69(48):1996-7. PubMed ID: 4453293
[No Abstract] [Full Text] [Related]
6. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
7. Treatment of drug overdosage with naloxone, a specific narcotic antagonist.
Evans LE; Swainson CP; Roscoe P; Prescott LF
Lancet; 1973 Mar; 1(7801):452-5. PubMed ID: 4120366
[No Abstract] [Full Text] [Related]
8. Abuse of pentazocine-naloxone combination.
Reed DA; Schnoll SH
JAMA; 1986 Nov; 256(18):2562-4. PubMed ID: 3773159
[TBL] [Abstract][Full Text] [Related]
9. A clinical comparison of the effects of oral and intramuscular administration of analgesics: pentazocine and phenazocine.
Beaver WT; Wallenstein SL; Houde RW; Rogers A
Clin Pharmacol Ther; 1968; 9(5):582-97. PubMed ID: 4877745
[No Abstract] [Full Text] [Related]
10. Rapid detoxification of the narcotic addict with naloxone hydrochloride. A preliminary report.
Kurland AA; McCabe L
J Clin Pharmacol; 1976 Jan; 16(1):66-74. PubMed ID: 1107361
[TBL] [Abstract][Full Text] [Related]
11. Pain and pentazocine: problems of control.
Still CN
South Med J; 1975 Jul; 68(7):805-7. PubMed ID: 1098156
[No Abstract] [Full Text] [Related]
12. Parenteral and oral pentazocine abuse.
Alarcon RD; Gelfond SD; Alarcon GS
Johns Hopkins Med J; 1971 Dec; 129(6):311-8. PubMed ID: 5133377
[No Abstract] [Full Text] [Related]
13. The misuse of pentazocine. Its dependence-producing potential.
JAMA; 1969 Sep; 209(10):1518-9. PubMed ID: 5820108
[No Abstract] [Full Text] [Related]
14. Pentazocine-induced fibrous myopathy.
Oh SJ; Rollins JL; Lewis I
JAMA; 1975 Jan; 231(3):271-3. PubMed ID: 1172732
[TBL] [Abstract][Full Text] [Related]
15. [Pentazocine dependance].
Idänpään-Heikkilä P
Duodecim; 1970; 86(9):519-22. PubMed ID: 5421401
[No Abstract] [Full Text] [Related]
16. [Our experience with a new synthetic analgesic preparation: WIN 20,228 (pentazocine)].
Musto P; Zaccagna CA; Vergano F
Minerva Anestesiol; 1969 May; 35():Suppl 5:1-5. PubMed ID: 4917375
[No Abstract] [Full Text] [Related]
17. Cutaneous complications of parenterally administered pentazocine.
Winfield JB; Greer K
JAMA; 1973 Oct; 226(2):189-90. PubMed ID: 4740912
[No Abstract] [Full Text] [Related]
18. Induction of physical dependence in rats by short interval medication.
Koga Y
Psychopharmacology (Berl); 1976 Nov; 50(2):153-7. PubMed ID: 826955
[TBL] [Abstract][Full Text] [Related]
19. Pentazocine analgesia: is there a niche for Talwin Nx?
Swift JQ; Hargreaves KM
Compendium; 1993 Aug; 14(8):1048, 1050 passim; quiz 1060. PubMed ID: 8269439
[TBL] [Abstract][Full Text] [Related]
20. Naloxone and the narcotic abuser: a controlled study of partial blockade.
Kurland AA; Hanlon TE; McCabe OL
Int J Addict; 1974; 9(5):663-72. PubMed ID: 4155406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
